Your browser doesn't support javascript.
loading
Whole exome sequencing of low grade serous ovarian carcinoma identifies genomic events associated with clinical outcome.
Thomson, John P; Hollis, Robert L; van Baal, Juliette; Ilenkovan, Narthana; Churchman, Michael; van de Vijver, Koen; Dijk, Frederike; Meynert, Alison M; Bartos, Clare; Rye, Tzyvia; Croy, Ian; Diana, Patricia; van Gent, Mignon; Creedon, Helen; Nirsimloo, Rachel; Nussey, Fiona; Lok, Christianne; Herrington, C Simon; Gourley, Charlie.
Afiliação
  • Thomson JP; Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
  • Hollis RL; Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
  • van Baal J; Department of Gynaecologic Oncology and Department of Pathology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, the Netherlands.
  • Ilenkovan N; Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK; Cancer Research UK Beatson Institute, Glasgow, United Kingdom.
  • Churchman M; Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
  • van de Vijver K; Department of Gynaecologic Oncology and Department of Pathology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, the Netherlands.
  • Dijk F; Department of Gynaecologic Oncology and Department of Pathology, Amsterdam University Medical Centres, Amsterdam, the Netherlands.
  • Meynert AM; MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
  • Bartos C; Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
  • Rye T; Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
  • Croy I; Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
  • Diana P; Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
  • van Gent M; Department of Gynaecologic Oncology and Department of Pathology, Amsterdam University Medical Centres, Amsterdam, the Netherlands.
  • Creedon H; Edinburgh Cancer Centre, Western General Hospital, NHS Lothian, Edinburgh, UK.
  • Nirsimloo R; Edinburgh Cancer Centre, Western General Hospital, NHS Lothian, Edinburgh, UK.
  • Nussey F; Edinburgh Cancer Centre, Western General Hospital, NHS Lothian, Edinburgh, UK.
  • Lok C; Department of Gynaecologic Oncology and Department of Pathology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, the Netherlands.
  • Herrington CS; Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
  • Gourley C; Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK. Electronic address: charlie.gourley@ed.ac.uk.
Gynecol Oncol ; 174: 157-166, 2023 07.
Article em En | MEDLINE | ID: mdl-37207500

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Cistadenocarcinoma Seroso / Cistadenocarcinoma Papilar Tipo de estudo: Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Gynecol Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Cistadenocarcinoma Seroso / Cistadenocarcinoma Papilar Tipo de estudo: Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Gynecol Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido